The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Robert W. Brueggemeier

College of Pharmacy

The Ohio State University

Columbus

OH 43210

USA

[email]@osu.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA. 1997 - 2010
  • Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, 500 West 12th Avenue, USA. 2001 - 2007
  • The College of Pharmacy and The OSU Comprehensive Cancer Center, The Ohio State University, Columbus 43210, U.S.A. 1997

References

  1. Selective regulation of aromatase expression for drug discovery. Brueggemeier, R.W., Su, B., Darby, M.V., Sugimoto, Y. J. Steroid Biochem. Mol. Biol. (2010) [Pubmed]
  2. Aromatase and COX in breast cancer: enzyme inhibitors and beyond. Brueggemeier, R.W., Su, B., Sugimoto, Y., Díaz-Cruz, E.S., Davis, D.D. J. Steroid Biochem. Mol. Biol. (2007) [Pubmed]
  3. Relationship between aromatase and cyclooxygenases in breast cancer: potential for new therapeutic approaches. Brueggemeier, R.W., Díaz-Cruz, E.S. Minerva Endocrinol. (2006) [Pubmed]
  4. Update on the use of aromatase inhibitors in breast cancer. Brueggemeier, R.W. Expert. Opin. Pharmacother (2006) [Pubmed]
  5. Aromatase inhibitors in the treatment of breast cancer. Brueggemeier, R.W., Hackett, J.C., Diaz-Cruz, E.S. Endocr. Rev. (2005) [Pubmed]
  6. Translational studies on aromatase, cyclooxygenases, and enzyme inhibitors in breast cancer. Brueggemeier, R.W., Díaz-Cruz, E.S., Li, P.K., Sugimoto, Y., Lin, Y.C., Shapiro, C.L. J. Steroid Biochem. Mol. Biol. (2005) [Pubmed]
  7. Aromatase and cyclooxygenases: enzymes in breast cancer. Brueggemeier, R.W., Richards, J.A., Petrel, T.A. J. Steroid Biochem. Mol. Biol. (2003) [Pubmed]
  8. Aromatase inhibitors in breast cancer therapy. Brueggemeier, R.W. Expert. Rev. Anticancer. Ther (2002) [Pubmed]
  9. Overview of the pharmacology of the aromatase inactivator exemestane. Brueggemeier, R.W. Breast Cancer Res. Treat. (2002) [Pubmed]
  10. Aromatase, aromatase inhibitors, and breast cancer. Brueggemeier, R.W. Am. J. Ther (2001) [Pubmed]
  11. 2-Methoxymethylestradiol: a new 2-methoxy estrogen analog that exhibits antiproliferative activity and alters tubulin dynamics. Brueggemeier, R.W., Bhat, A.S., Lovely, C.J., Coughenour, H.D., Joomprabutra, S., Weitzel, D.H., Vandre, D.D., Yusuf, F., Burak, W.E. J. Steroid Biochem. Mol. Biol. (2001) [Pubmed]
  12. Effects of phytoestrogens and synthetic combinatorial libraries on aromatase, estrogen biosynthesis, and metabolism. Brueggemeier, R.W., Gu, X., Mobley, J.A., Joomprabutra, S., Bhat, A.S., Whetstone, J.L. Ann. N. Y. Acad. Sci. (2001) [Pubmed]
  13. Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens. Brueggemeier, R.W., Quinn, A.L., Parrett, M.L., Joarder, F.S., Harris, R.E., Robertson, F.M. Cancer Lett. (1999) [Pubmed]
  14. Aromatase inhibition in JAr choriocarcinoma cells by 7alpha-arylaliphatic androgens. Brueggemeier, R.W., Gilbert, N.E., Gu, X., O'Reilly, J.M., Lovely, C.J. J. Steroid Biochem. Mol. Biol. (1997) [Pubmed]
  15. Biochemistry and pharmacology of 7alpha-substituted androstenediones as aromatase inhibitors. Brueggemeier, R.W., O'Reilly, J.M., Lovely, C.J., Ward, P.J., Quinn, A.L., Baker, D., Darby, M.V., Gu, X.J., Gilbert, N.E. J. Steroid Biochem. Mol. Biol. (1997) [Pubmed]
 
WikiGenes - Universities